With Amgen set to spend more than $10 billion to buy Onyx, investors are wondering if these super-sized biopharma acquisitions are worth it. More
Zale: The Perpetual Red Ink Machine Finally Runs Black
Mall jewelry retailer giant Zale just posted its full-year profit since 2008, and the stock tacked on another 20% gain to its 2013 doubling as a result. More
4 Packaged Foods Stocks to Buy Now
The grades of four Packaged Foods stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More
7 Insurance Stocks to Buy Now
The grades of seven Insurance stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating. More
6 Biotechnology Stocks to Buy Now
The grades of six Biotechnology stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating. More
3 Service Stocks to Buy Now
The grades of three Service stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More
